León Xavier, del Prado Venegas María, Orús César, López Montserrat, García Jacinto, Quer Miquel
Department of Otolaryngology/Head and Neck Surgery, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Avda., San Antoni Ma Claret, 167, 08025 Barcelona, Spain.
Cancer Causes Control. 2009 Jul;20(5):645-52. doi: 10.1007/s10552-008-9277-8. Epub 2008 Dec 6.
To evaluate the influence of persistent tobacco and alcohol use on the risk of a second metachronous neoplasm in the aerodigestive tract in head and neck squamous cell carcinoma (HNSCC) patients.
A matched case-control study was carried out in 514 patients with HNSCC. Case patients developed a second metachronous neoplasm in the aerodigestive tract after treatment of an index HNSCC. A patient free of second neoplasm was individually matched to every case patient by location of the index tumor, tumor stage, sex, previous tobacco and alcohol consumption, age, general health status, and treatment. Data about persistence in tobacco and alcohol consumption after treatment of the index tumor was collected retrospectively. A validation study was carried out to confirm the adequacy of this retrospective information.
Persistent tobacco smoking and alcohol drinking after treatment of a HNSCC contributed to the risk of appearance of second neoplasm. The odds ratio of a second neoplasm for patients who continued to smoke was 2.9 (95% CI OR 1.8-4.1), and for patients who continued to use alcohol it was 5.2 (95% CI OR 3.3-7.9). There was a strong association between persistence of tobacco and alcohol use after treatment of the HNSCC index tumor. According to the attributable risk estimation, persistent tobacco and alcohol consumption would be responsible for one-third of the second neoplasms in the patients with a HNSCC index tumor.
Persistence of tobacco and alcohol use after treatment of a HNSCC had a significant influence on the appearance of a second neoplasm in the aerodigestive tract. Cessation of tobacco and alcohol use should be a major goal after treatment of a HNSCC.
评估持续吸烟和饮酒对头颈鳞状细胞癌(HNSCC)患者气道消化道发生异时性第二肿瘤风险的影响。
对514例HNSCC患者进行配对病例对照研究。病例组患者在原发HNSCC治疗后气道消化道出现异时性第二肿瘤。按照原发肿瘤部位、肿瘤分期、性别、既往吸烟和饮酒情况、年龄、总体健康状况及治疗方式,为每例病例组患者匹配一名无第二肿瘤的对照患者。回顾性收集原发肿瘤治疗后持续吸烟和饮酒的数据。开展验证研究以确认该回顾性信息的充分性。
HNSCC治疗后持续吸烟和饮酒会增加出现第二肿瘤的风险。持续吸烟患者发生第二肿瘤的优势比为2.9(95%可信区间OR 1.8 - 4.1),持续饮酒患者为5.2(95%可信区间OR 3.3 - 7.9)。HNSCC原发肿瘤治疗后持续吸烟和饮酒之间存在强关联。根据归因风险估计,持续吸烟和饮酒导致HNSCC原发肿瘤患者中三分之一的患者发生第二肿瘤。
HNSCC治疗后持续吸烟和饮酒对气道消化道出现第二肿瘤有显著影响。戒烟戒酒应成为HNSCC治疗后的主要目标。